Bruns Ingmar is a corporate insider who has filed 2 SEC Form 4 transactions in the past 12 months across 0 companies. No open-market purchases were recorded; all transactions were sales or other dispositions. Insider activity is one signal among many — past performance does not guarantee future results.

Bruns Ingmar

CMO

Latest Insider Transactions

3 transactions (past 365 days)

ZNTL
CMO
Sale
$802
335 shares @ $2.39
Filed 2026-02-10Trade 2026-02-09
Zentalis Pharmaceuticals, Inc.
ZNTL
CMO
Sale
$7.2K
2,962 shares @ $2.43
Filed 2026-02-10Trade 2026-02-06
Zentalis Pharmaceuticals, Inc.
ZNTL
CMO
Award
$0
365,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-08
Zentalis Pharmaceuticals, Inc.